Peng Y - Search Results

1

The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook.

Song X, Peng Y, Wang X, Chen Q, Lan X, Shi F. Song X, et al. Among authors: peng y. Clin Transl Oncol. 2023 Jun;25(6):1545-1553. doi: 10.1007/s12094-022-03065-6. Epub 2022 Dec 31. Clin Transl Oncol. 2023. PMID: 36587109 Review.

2

Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.

Song X, Peng Y, Wang X, Chen Y, Jin L, Yang T, Qian M, Ni W, Tong X, Lan J. Song X, et al. Among authors: peng y. Acta Haematol. 2018;139(2):115-127. doi: 10.1159/000486228. Epub 2018 Feb 16. Acta Haematol. 2018. PMID: 29455198

3

Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.

Peng Y, Song X, Lan J, Wang X, Wang M. Peng Y, et al. Medicine (Baltimore). 2021 Jan 29;100(4):e23447. doi: 10.1097/MD.0000000000023447. Medicine (Baltimore). 2021. PMID: 33530159 Free PMC article.

4

Therapeutic applications of toll-like receptors (TLRs) agonists in AML.

Peng Y, Wang Y, Wang M, Lan J, Chen Y. Peng Y, et al. Clin Transl Oncol. 2022 Dec;24(12):2319-2329. doi: 10.1007/s12094-022-02917-5. Epub 2022 Aug 13. Clin Transl Oncol. 2022. PMID: 35962918 Review.

5

LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.

Song X, Chen Y, Peng Y, Wang X, Zheng S, Shi F, Lan J. Song X, et al. Among authors: peng y. Evid Based Complement Alternat Med. 2022 Oct 6;2022:2295044. doi: 10.1155/2022/2295044. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36248434 Free PMC article. Retracted.

6

The prognostic, immunological and single-cell features of m6A molecules in cervical cancer.

Zhu X, Song X, Chen Q, Peng Y, Shi F. Zhu X, et al. Among authors: peng y. Cell Mol Biol (Noisy-le-grand). 2023 Sep 30;69(9):89-99. doi: 10.14715/cmb/2023.69.9.13. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37807329

7

Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.

Chen Y, Li M, Wu H, Yuan S, Xia Y, Wang Y, Peng Y, Lan J, Wang Y. Chen Y, et al. Among authors: peng y. J Cancer. 2022 Apr 18;13(7):2301-2311. doi: 10.7150/jca.66175. eCollection 2022. J Cancer. 2022. PMID: 35517404 Free PMC article.

8

Dysbiosis and primary B-cell immunodeficiencies: current knowledge and future perspective.

Peng Y, Chen Y, Wang Y, Wang W, Qiao S, Lan J, Wang M. Peng Y, et al. Immunol Res. 2023 Aug;71(4):528-536. doi: 10.1007/s12026-023-09365-5. Epub 2023 Mar 18. Immunol Res. 2023. PMID: 36933165 Review.

9

Rhizomucor pusillus Infection in a Patient with Acute Myeloid Leukaemia After Haematopoietic Stem Cell Transplantation: Clinical Impact of Metagenomics Next-Generation Sequencing.

Liu L, Wu H, Liang J, Wu W, Peng Y, Zhou H, Li X. Liu L, et al. Among authors: peng y. Infect Drug Resist. 2022 Aug 6;15:4285-4290. doi: 10.2147/IDR.S376045. eCollection 2022. Infect Drug Resist. 2022. PMID: 35965849 Free PMC article.

10

[A case report of gastric cancer complicated with chronic lymphocytic leukemia].

Zheng S, Wang H, Wu M, Chen Y, Tao H, Peng Y, Qiu L. Zheng S, et al. Among authors: peng y. Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):546. doi: 10.3760/cma.j.issn.0253-2727.2015.07.003. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26304074 Free PMC article. Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,439 results

Search Page